Agenda - Wednesday, September 17th, 2025 - Main Conference Day One

Showing 1 of 1 Streams

Gene Therapy Manufacturing & Analytics

8:55am - 9:00am

Chairperson’s Opening Remarks: Gene Therapy Manufacturing & Analytics

9:00am - 9:30am

Keynote Panel Discussion: Strategies for Scaling Up, Accelerating and Commercializing Gene Therapy Manufacturing

Ying Cai - MSAT Executive Director, Ultragenyx Pharmaceutical

9:30am - 10:00am

Case Study on Tech Transfer and Scale Up – How to Translate from Small to Large Scale / GMP

Phillip Ramsey - Senior Vice President, Technical Operations, Sangamo Therapeutics

10:00am - 10:30am

Tech Transfer Best Practices to CMOs

Jordan Ball - Sr. Manager, Technology Transfer, Regeneron

Showing 1 of 1 Streams

Gene Therapy Manufacturing & Analytics

11:30am - 12:00pm

Revolutionizing Large Scale Gene Therapy Production: Boosting Cell Density and Cell Specific Productivity with Advanced Producer Cell Lines

Improvements and innovations in cell line development & engineering to increase yields for gene therapies
Application of producer cell lines to lower transfection vector costs: Data for large scale use of stable cell lines
Scalability of producer cell lines? Case studies on experiences at larger scales

12:00pm - 12:30pm

Expanding the Upstream Toolbox: Enabling High-Productivity, Robust, and Scalable AAV Production

Huize Yan - Sr. Process Development Scientist – Upstream, Spark Therapeutics

12:30pm - 1:00pm

Next-Gen Innovations: Transforming Upstream Process Development in Gene Therapy

Spotlight Presentation – Calling all Technology Thought Leaders!

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.

Showing 1 of 1 Streams

Gene Therapy Manufacturing & Analytics

2:10pm - 2:15pm

Chairperson’s Opening Remarks: Gene Therapy Manufacturing & Analytics

2:15pm - 2:45pm

Rapid Development of AAV Purification Process Without Sacrificing Recovery

Hunter Reese - Scientist II, AskBio

2:45pm - 3:15pm

Application of Novel Technologies to Deliver AAV Downstream Processes with Higher Yield and Better Quality

Junfen Ma - Head of Genomic Medicine Purification Process Development, Sanofi

3:15pm - 3:45pm

Optimizing Gene Therapy Productivity: Cutting-Edge Technology Innovations for Superior Downstream Processing

Spotlight Presentation – Calling all Technology Thought Leaders!

Showing 1 of 1 Streams

Gene Therapy Manufacturing & Analytics

4:30pm - 5:00pm

Detectability and Propagation of MVM in HEK293 Cells: What it means for your Viral Safety Strategy

Dana Schreffler - Sr. Manager QC Viral Safety, Regeneron

5:00pm - 5:30pm

Mastering hcDNA: A Harmonized CMC Approach in AAV Therapies

Parag Kumthekar - Gene Therapy Downstream Process Development Lead, UCB Pharma

Wednesday, September 17th, 2025 - Main Conference Day OneWednesday, 17 September 2025 - ET (Eastern Time, GMT-05:00)